10 June 2016 - CADTH calls for patient input on a submission from Teva Pharmaceuticals for Fentora (fentanyl citrate).

Teva Pharmaceuticals is seeking a recommendation from CADTH on the use of Fentora to treat adult patients with breakthrough cancer pain.

The submission is due on 11 July 2016; patient input closes on 2 August 2016.

For more details, go to: https://www.cadth.ca/fentanyl-citrate-19?utm_source=%2ALIVE%2A+CADTH%2FACMTS+Confirmed+Subscribers&utm_campaign=03d0494986-Call-for-PI-Fentora&utm_medium=email&utm_term=0_2e3705996c-03d0494986-262951505